Greenwich LifeSciences, Inc. (GLSI)
 NASDAQ: GLSI · Real-Time Price · USD
 9.19
 +0.04 (0.44%)
  Oct 30, 2025, 4:00 PM EDT - Market closed
Greenwich LifeSciences Market Cap
Greenwich LifeSciences has a market cap or net worth of $125.26 million as of October 30, 2025. Its market cap has decreased by -32.70% in one year.
Market Cap 
 125.26M
Enterprise Value 
 122.14M
1-Year Change 
 -32.70%
Ranking 
 Category 
 Stock Price 
$9.19
Market Cap Chart
Since the IPO on September 25, 2020, Greenwich LifeSciences's market cap has increased from $68.69M to $125.26M, an increase of 82.36%. That is a compound annual growth rate of 12.51%.
Market Cap History
| Date | Market Cap | % Change | 
|---|---|---|
| Oct 30, 2025 | 125.26M | -15.14% | 
| Dec 31, 2024 | 147.61M | 9.21% | 
| Dec 29, 2023 | 135.16M | -30.79% | 
| Dec 30, 2022 | 195.29M | -38.84% | 
| Dec 31, 2021 | 319.29M | -31.08% | 
| Dec 31, 2020 | 463.30M | 574.50% | 
| Sep 25, 2020 | Upgrade Pro | Upgrade Pro | 
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
 Full DefinitionRelated Stocks
| Company | Market Cap | 
|---|---|
| Eli Lilly and Company | 736.23B | 
| Johnson & Johnson | 449.42B | 
| AbbVie | 401.96B | 
| UnitedHealth Group | 333.14B | 
| AstraZeneca | 255.54B | 
| Novartis AG | 239.27B | 
| Novo Nordisk | 229.86B | 
| Abbott Laboratories | 220.36B |